D-Arabitol is an orally active D-enantiomer that modulates gut microbiota, increases short-chain fatty acids, and promotes AMPK-PGC-1α-related browning of white adipose tissue. It improves weight gain, fat accumulation, insulin resistance, lipid deposition, and inflammatory responses, making it applicable to obesity-related research.
- Modulates gut microbiota composition.
- Increases short-chain fatty acids.
- Promotes AMPK-PGC-1α-related browning of white adipose tissue.
- Improves weight gain, fat accumulation, insulin resistance, lipid deposition, and inflammatory responses.
- Serves as a sole carbon/energy source for *Bacillus methanolicus* MGA3.
- Applicable to obesity-related research.